NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis

Ítems similars

• Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
  per: Cristiano Xavier Lima, et al.
  Publicat: (2015-01-01)
• CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model
  per: Xavier Chauchet, et al.
  Publicat: (2022-05-01)
• Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies
  per: Evgeny Lvovich Nasonov, et al.
  Publicat: (2012-06-01)
• ESTATES & GAZETTE NO.0101 - 0103 2001
• Raised circulating tenascin-C in rheumatoid arthritis.
  per: Page, T, et al.
  Publicat: (2012)